Concepedia

Eric M. Kanza

EM

Statistics

Publications

4

Citations

498

H-Index

4

Active since

2018

Affiliations

World Health Organization(Current)

Université Catholique du Graben

Liberian Institute for Biomedical Research

University of Ghana

University of Health and Allied Sciences

Eric M. Kanza is an author at World Health Organization specializing in ivermectin treatment, infectious diseases, and infection prevention.

Publications per year

2018–2023

4

Publications

4

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Nicholas Opoku, Didier Bakajika, Eric M. Kanza et al. · The Lancet · 2018 · 306 citations · Full text

, , +17

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

Didier Bakajika, Eric M. Kanza, Nicholas Opoku et al. · PLoS neglected tropical diseases · 2022 · 148 citations · Full text

, , +9

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

Klodeta Kura, Philip Milton, Jonathan I. D. Hamley et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 2023 · 33 citations · Full text

, , +15

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

Nicholas Opoku, Felix Doe, Bettina Dubben et al. · PLoS neglected tropical diseases · 2023 · 11 citations · Full text

, , +17

1–4 of 4